Polyrizon Ltd. (NASDAQ: PLRZ) (the “Company”), a pre-clinical-stage biotechnology company developing intranasal protective solutions, today announced that it has entered into definitive ...
With Go, Ovejero points to a recurring class of bugs around nil handling. Go does not distinguish between nillable and ...